0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Oligonucleotide Conjugates Market Research Report 2024
Published Date: November 2024
|
Report Code: QYRE-Auto-24V18230
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Oligonucleotide Conjugates Market Research Report 2024
BUY CHAPTERS

Global Oligonucleotide Conjugates Market Research Report 2024

Code: QYRE-Auto-24V18230
Report
November 2024
Pages:104
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Oligonucleotide Conjugates Market

The global Oligonucleotide Conjugates market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
Oligonucleotide Conjugates refers to the conjugation of oligonucleotides with other biomolecules such as peptides, antibodies, etc. This conjugation can be used in a variety of research and applications, including: drug delivery, vaccine development, and gene therapy.
North American market for Oligonucleotide Conjugates is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Oligonucleotide Conjugates is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Oligonucleotide Conjugates include WuXi TIDES, Bio-Synthesis Inc, Creative Biolabs, Creative Biogene (IntegrateRNA), CPC Scientific Inc., BOCSCI Inc., LifeTein, Ajinomoto, SBS Genetech, Medtide Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Oligonucleotide Conjugates, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oligonucleotide Conjugates.
The Oligonucleotide Conjugates market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oligonucleotide Conjugates market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oligonucleotide Conjugates manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Oligonucleotide Conjugates Market Report

Report Metric Details
Report Name Oligonucleotide Conjugates Market
by Type
  • Oligonucleotide-Peptide
  • Oligonucleotide-Antibody
  • Oligonucleotide-Lipid
  • Oligonucleotide-Toxin
  • Oligonucleotide-GalNAc
  • Other
by Application
  • Gene Therapy
  • Drug Delivery
  • Vaccine Development
Production by Region
  • North America
  • Europe
  • China
  • Japan
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company WuXi TIDES, Bio-Synthesis Inc, Creative Biolabs, Creative Biogene (IntegrateRNA), CPC Scientific Inc., BOCSCI Inc., LifeTein, Ajinomoto, SBS Genetech, Medtide Inc., Kaneka Corporation(Eurogentec), Rockland, CellMosaic, Leinco, Lonza, ChemExpress, Hongene Biotech, GTP Bioways, Suzhou Biosyntech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Oligonucleotide Conjugates manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Oligonucleotide Conjugates in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Oligonucleotide Conjugates Market report?

Ans: The main players in the Oligonucleotide Conjugates Market are WuXi TIDES, Bio-Synthesis Inc, Creative Biolabs, Creative Biogene (IntegrateRNA), CPC Scientific Inc., BOCSCI Inc., LifeTein, Ajinomoto, SBS Genetech, Medtide Inc., Kaneka Corporation(Eurogentec), Rockland, CellMosaic, Leinco, Lonza, ChemExpress, Hongene Biotech, GTP Bioways, Suzhou Biosyntech

What are the Application segmentation covered in the Oligonucleotide Conjugates Market report?

Ans: The Applications covered in the Oligonucleotide Conjugates Market report are Gene Therapy, Drug Delivery, Vaccine Development

What are the Type segmentation covered in the Oligonucleotide Conjugates Market report?

Ans: The Types covered in the Oligonucleotide Conjugates Market report are Oligonucleotide-Peptide, Oligonucleotide-Antibody, Oligonucleotide-Lipid, Oligonucleotide-Toxin, Oligonucleotide-GalNAc, Other

1 Oligonucleotide Conjugates Market Overview
1.1 Product Definition
1.2 Oligonucleotide Conjugates by Type
1.2.1 Global Oligonucleotide Conjugates Market Value Comparison by Type (2024-2030)
1.2.2 Oligonucleotide-Peptide
1.2.3 Oligonucleotide-Antibody
1.2.4 Oligonucleotide-Lipid
1.2.5 Oligonucleotide-Toxin
1.2.6 Oligonucleotide-GalNAc
1.2.7 Other
1.3 Oligonucleotide Conjugates by Application
1.3.1 Global Oligonucleotide Conjugates Market Value by Application (2024-2030)
1.3.2 Gene Therapy
1.3.3 Drug Delivery
1.3.4 Vaccine Development
1.4 Global Oligonucleotide Conjugates Market Size Estimates and Forecasts
1.4.1 Global Oligonucleotide Conjugates Revenue 2019-2030
1.4.2 Global Oligonucleotide Conjugates Sales 2019-2030
1.4.3 Global Oligonucleotide Conjugates Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Oligonucleotide Conjugates Market Competition by Manufacturers
2.1 Global Oligonucleotide Conjugates Sales Market Share by Manufacturers (2019-2024)
2.2 Global Oligonucleotide Conjugates Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Oligonucleotide Conjugates Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Oligonucleotide Conjugates, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Oligonucleotide Conjugates, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oligonucleotide Conjugates, Product Type & Application
2.7 Global Key Manufacturers of Oligonucleotide Conjugates, Date of Enter into This Industry
2.8 Global Oligonucleotide Conjugates Market Competitive Situation and Trends
2.8.1 Global Oligonucleotide Conjugates Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Oligonucleotide Conjugates Players Market Share by Revenue
2.8.3 Global Oligonucleotide Conjugates Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Oligonucleotide Conjugates Market Scenario by Region
3.1 Global Oligonucleotide Conjugates Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Oligonucleotide Conjugates Sales by Region: 2019-2030
3.2.1 Global Oligonucleotide Conjugates Sales by Region: 2019-2024
3.2.2 Global Oligonucleotide Conjugates Sales by Region: 2025-2030
3.3 Global Oligonucleotide Conjugates Revenue by Region: 2019-2030
3.3.1 Global Oligonucleotide Conjugates Revenue by Region: 2019-2024
3.3.2 Global Oligonucleotide Conjugates Revenue by Region: 2025-2030
3.4 North America Oligonucleotide Conjugates Market Facts & Figures by Country
3.4.1 North America Oligonucleotide Conjugates Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Oligonucleotide Conjugates Sales by Country (2019-2030)
3.4.3 North America Oligonucleotide Conjugates Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Oligonucleotide Conjugates Market Facts & Figures by Country
3.5.1 Europe Oligonucleotide Conjugates Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Oligonucleotide Conjugates Sales by Country (2019-2030)
3.5.3 Europe Oligonucleotide Conjugates Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oligonucleotide Conjugates Market Facts & Figures by Region
3.6.1 Asia Pacific Oligonucleotide Conjugates Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Oligonucleotide Conjugates Sales by Region (2019-2030)
3.6.3 Asia Pacific Oligonucleotide Conjugates Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Oligonucleotide Conjugates Market Facts & Figures by Country
3.7.1 Latin America Oligonucleotide Conjugates Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Oligonucleotide Conjugates Sales by Country (2019-2030)
3.7.3 Latin America Oligonucleotide Conjugates Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Oligonucleotide Conjugates Market Facts & Figures by Country
3.8.1 Middle East and Africa Oligonucleotide Conjugates Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Oligonucleotide Conjugates Sales by Country (2019-2030)
3.8.3 Middle East and Africa Oligonucleotide Conjugates Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oligonucleotide Conjugates Sales by Type (2019-2030)
4.1.1 Global Oligonucleotide Conjugates Sales by Type (2019-2024)
4.1.2 Global Oligonucleotide Conjugates Sales by Type (2025-2030)
4.1.3 Global Oligonucleotide Conjugates Sales Market Share by Type (2019-2030)
4.2 Global Oligonucleotide Conjugates Revenue by Type (2019-2030)
4.2.1 Global Oligonucleotide Conjugates Revenue by Type (2019-2024)
4.2.2 Global Oligonucleotide Conjugates Revenue by Type (2025-2030)
4.2.3 Global Oligonucleotide Conjugates Revenue Market Share by Type (2019-2030)
4.3 Global Oligonucleotide Conjugates Price by Type (2019-2030)
5 Segment by Application
5.1 Global Oligonucleotide Conjugates Sales by Application (2019-2030)
5.1.1 Global Oligonucleotide Conjugates Sales by Application (2019-2024)
5.1.2 Global Oligonucleotide Conjugates Sales by Application (2025-2030)
5.1.3 Global Oligonucleotide Conjugates Sales Market Share by Application (2019-2030)
5.2 Global Oligonucleotide Conjugates Revenue by Application (2019-2030)
5.2.1 Global Oligonucleotide Conjugates Revenue by Application (2019-2024)
5.2.2 Global Oligonucleotide Conjugates Revenue by Application (2025-2030)
5.2.3 Global Oligonucleotide Conjugates Revenue Market Share by Application (2019-2030)
5.3 Global Oligonucleotide Conjugates Price by Application (2019-2030)
6 Key Companies Profiled
6.1 WuXi TIDES
6.1.1 WuXi TIDES Company Information
6.1.2 WuXi TIDES Description and Business Overview
6.1.3 WuXi TIDES Oligonucleotide Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.1.4 WuXi TIDES Oligonucleotide Conjugates Product Portfolio
6.1.5 WuXi TIDES Recent Developments/Updates
6.2 Bio-Synthesis Inc
6.2.1 Bio-Synthesis Inc Company Information
6.2.2 Bio-Synthesis Inc Description and Business Overview
6.2.3 Bio-Synthesis Inc Oligonucleotide Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bio-Synthesis Inc Oligonucleotide Conjugates Product Portfolio
6.2.5 Bio-Synthesis Inc Recent Developments/Updates
6.3 Creative Biolabs
6.3.1 Creative Biolabs Company Information
6.3.2 Creative Biolabs Description and Business Overview
6.3.3 Creative Biolabs Oligonucleotide Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Creative Biolabs Oligonucleotide Conjugates Product Portfolio
6.3.5 Creative Biolabs Recent Developments/Updates
6.4 Creative Biogene (IntegrateRNA)
6.4.1 Creative Biogene (IntegrateRNA) Company Information
6.4.2 Creative Biogene (IntegrateRNA) Description and Business Overview
6.4.3 Creative Biogene (IntegrateRNA) Oligonucleotide Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Creative Biogene (IntegrateRNA) Oligonucleotide Conjugates Product Portfolio
6.4.5 Creative Biogene (IntegrateRNA) Recent Developments/Updates
6.5 CPC Scientific Inc.
6.5.1 CPC Scientific Inc. Company Information
6.5.2 CPC Scientific Inc. Description and Business Overview
6.5.3 CPC Scientific Inc. Oligonucleotide Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.5.4 CPC Scientific Inc. Oligonucleotide Conjugates Product Portfolio
6.5.5 CPC Scientific Inc. Recent Developments/Updates
6.6 BOCSCI Inc.
6.6.1 BOCSCI Inc. Company Information
6.6.2 BOCSCI Inc. Description and Business Overview
6.6.3 BOCSCI Inc. Oligonucleotide Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.6.4 BOCSCI Inc. Oligonucleotide Conjugates Product Portfolio
6.6.5 BOCSCI Inc. Recent Developments/Updates
6.7 LifeTein
6.7.1 LifeTein Company Information
6.7.2 LifeTein Description and Business Overview
6.7.3 LifeTein Oligonucleotide Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.7.4 LifeTein Oligonucleotide Conjugates Product Portfolio
6.7.5 LifeTein Recent Developments/Updates
6.8 Ajinomoto
6.8.1 Ajinomoto Company Information
6.8.2 Ajinomoto Description and Business Overview
6.8.3 Ajinomoto Oligonucleotide Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Ajinomoto Oligonucleotide Conjugates Product Portfolio
6.8.5 Ajinomoto Recent Developments/Updates
6.9 SBS Genetech
6.9.1 SBS Genetech Company Information
6.9.2 SBS Genetech Description and Business Overview
6.9.3 SBS Genetech Oligonucleotide Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.9.4 SBS Genetech Oligonucleotide Conjugates Product Portfolio
6.9.5 SBS Genetech Recent Developments/Updates
6.10 Medtide Inc.
6.10.1 Medtide Inc. Company Information
6.10.2 Medtide Inc. Description and Business Overview
6.10.3 Medtide Inc. Oligonucleotide Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Medtide Inc. Oligonucleotide Conjugates Product Portfolio
6.10.5 Medtide Inc. Recent Developments/Updates
6.11 Kaneka Corporation(Eurogentec)
6.11.1 Kaneka Corporation(Eurogentec) Company Information
6.11.2 Kaneka Corporation(Eurogentec) Description and Business Overview
6.11.3 Kaneka Corporation(Eurogentec) Oligonucleotide Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Kaneka Corporation(Eurogentec) Oligonucleotide Conjugates Product Portfolio
6.11.5 Kaneka Corporation(Eurogentec) Recent Developments/Updates
6.12 Rockland
6.12.1 Rockland Company Information
6.12.2 Rockland Description and Business Overview
6.12.3 Rockland Oligonucleotide Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Rockland Oligonucleotide Conjugates Product Portfolio
6.12.5 Rockland Recent Developments/Updates
6.13 CellMosaic
6.13.1 CellMosaic Company Information
6.13.2 CellMosaic Description and Business Overview
6.13.3 CellMosaic Oligonucleotide Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.13.4 CellMosaic Oligonucleotide Conjugates Product Portfolio
6.13.5 CellMosaic Recent Developments/Updates
6.14 Leinco
6.14.1 Leinco Company Information
6.14.2 Leinco Description and Business Overview
6.14.3 Leinco Oligonucleotide Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Leinco Oligonucleotide Conjugates Product Portfolio
6.14.5 Leinco Recent Developments/Updates
6.15 Lonza
6.15.1 Lonza Company Information
6.15.2 Lonza Description and Business Overview
6.15.3 Lonza Oligonucleotide Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Lonza Oligonucleotide Conjugates Product Portfolio
6.15.5 Lonza Recent Developments/Updates
6.16 ChemExpress
6.16.1 ChemExpress Company Information
6.16.2 ChemExpress Description and Business Overview
6.16.3 ChemExpress Oligonucleotide Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.16.4 ChemExpress Oligonucleotide Conjugates Product Portfolio
6.16.5 ChemExpress Recent Developments/Updates
6.17 Hongene Biotech
6.17.1 Hongene Biotech Company Information
6.17.2 Hongene Biotech Description and Business Overview
6.17.3 Hongene Biotech Oligonucleotide Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Hongene Biotech Oligonucleotide Conjugates Product Portfolio
6.17.5 Hongene Biotech Recent Developments/Updates
6.18 GTP Bioways
6.18.1 GTP Bioways Company Information
6.18.2 GTP Bioways Description and Business Overview
6.18.3 GTP Bioways Oligonucleotide Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.18.4 GTP Bioways Oligonucleotide Conjugates Product Portfolio
6.18.5 GTP Bioways Recent Developments/Updates
6.19 Suzhou Biosyntech
6.19.1 Suzhou Biosyntech Company Information
6.19.2 Suzhou Biosyntech Description and Business Overview
6.19.3 Suzhou Biosyntech Oligonucleotide Conjugates Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Suzhou Biosyntech Oligonucleotide Conjugates Product Portfolio
6.19.5 Suzhou Biosyntech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oligonucleotide Conjugates Industry Chain Analysis
7.2 Oligonucleotide Conjugates Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oligonucleotide Conjugates Production Mode & Process
7.4 Oligonucleotide Conjugates Sales and Marketing
7.4.1 Oligonucleotide Conjugates Sales Channels
7.4.2 Oligonucleotide Conjugates Distributors
7.5 Oligonucleotide Conjugates Customers
8 Oligonucleotide Conjugates Market Dynamics
8.1 Oligonucleotide Conjugates Industry Trends
8.2 Oligonucleotide Conjugates Market Drivers
8.3 Oligonucleotide Conjugates Market Challenges
8.4 Oligonucleotide Conjugates Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Oligonucleotide Conjugates Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Oligonucleotide Conjugates Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Oligonucleotide Conjugates Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Oligonucleotide Conjugates Sales (Kg) of Key Manufacturers (2019-2024)
 Table 5. Global Oligonucleotide Conjugates Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Oligonucleotide Conjugates Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Oligonucleotide Conjugates Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Oligonucleotide Conjugates Average Price (US$/g) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Oligonucleotide Conjugates, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Oligonucleotide Conjugates, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Oligonucleotide Conjugates, Product Type & Application
 Table 12. Global Key Manufacturers of Oligonucleotide Conjugates, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Oligonucleotide Conjugates by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligonucleotide Conjugates as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Oligonucleotide Conjugates Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Oligonucleotide Conjugates Sales by Region (2019-2024) & (Kg)
 Table 18. Global Oligonucleotide Conjugates Sales Market Share by Region (2019-2024)
 Table 19. Global Oligonucleotide Conjugates Sales by Region (2025-2030) & (Kg)
 Table 20. Global Oligonucleotide Conjugates Sales Market Share by Region (2025-2030)
 Table 21. Global Oligonucleotide Conjugates Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Oligonucleotide Conjugates Revenue Market Share by Region (2019-2024)
 Table 23. Global Oligonucleotide Conjugates Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Oligonucleotide Conjugates Revenue Market Share by Region (2025-2030)
 Table 25. North America Oligonucleotide Conjugates Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Oligonucleotide Conjugates Sales by Country (2019-2024) & (Kg)
 Table 27. North America Oligonucleotide Conjugates Sales by Country (2025-2030) & (Kg)
 Table 28. North America Oligonucleotide Conjugates Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Oligonucleotide Conjugates Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Oligonucleotide Conjugates Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Oligonucleotide Conjugates Sales by Country (2019-2024) & (Kg)
 Table 32. Europe Oligonucleotide Conjugates Sales by Country (2025-2030) & (Kg)
 Table 33. Europe Oligonucleotide Conjugates Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Oligonucleotide Conjugates Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Oligonucleotide Conjugates Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Oligonucleotide Conjugates Sales by Region (2019-2024) & (Kg)
 Table 37. Asia Pacific Oligonucleotide Conjugates Sales by Region (2025-2030) & (Kg)
 Table 38. Asia Pacific Oligonucleotide Conjugates Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Oligonucleotide Conjugates Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Oligonucleotide Conjugates Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Oligonucleotide Conjugates Sales by Country (2019-2024) & (Kg)
 Table 42. Latin America Oligonucleotide Conjugates Sales by Country (2025-2030) & (Kg)
 Table 43. Latin America Oligonucleotide Conjugates Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Oligonucleotide Conjugates Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Oligonucleotide Conjugates Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Oligonucleotide Conjugates Sales by Country (2019-2024) & (Kg)
 Table 47. Middle East and Africa Oligonucleotide Conjugates Sales by Country (2025-2030) & (Kg)
 Table 48. Middle East and Africa Oligonucleotide Conjugates Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Oligonucleotide Conjugates Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Oligonucleotide Conjugates Sales (Kg) by Type (2019-2024)
 Table 51. Global Oligonucleotide Conjugates Sales (Kg) by Type (2025-2030)
 Table 52. Global Oligonucleotide Conjugates Sales Market Share by Type (2019-2024)
 Table 53. Global Oligonucleotide Conjugates Sales Market Share by Type (2025-2030)
 Table 54. Global Oligonucleotide Conjugates Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Oligonucleotide Conjugates Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Oligonucleotide Conjugates Revenue Market Share by Type (2019-2024)
 Table 57. Global Oligonucleotide Conjugates Revenue Market Share by Type (2025-2030)
 Table 58. Global Oligonucleotide Conjugates Price (US$/g) by Type (2019-2024)
 Table 59. Global Oligonucleotide Conjugates Price (US$/g) by Type (2025-2030)
 Table 60. Global Oligonucleotide Conjugates Sales (Kg) by Application (2019-2024)
 Table 61. Global Oligonucleotide Conjugates Sales (Kg) by Application (2025-2030)
 Table 62. Global Oligonucleotide Conjugates Sales Market Share by Application (2019-2024)
 Table 63. Global Oligonucleotide Conjugates Sales Market Share by Application (2025-2030)
 Table 64. Global Oligonucleotide Conjugates Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Oligonucleotide Conjugates Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Oligonucleotide Conjugates Revenue Market Share by Application (2019-2024)
 Table 67. Global Oligonucleotide Conjugates Revenue Market Share by Application (2025-2030)
 Table 68. Global Oligonucleotide Conjugates Price (US$/g) by Application (2019-2024)
 Table 69. Global Oligonucleotide Conjugates Price (US$/g) by Application (2025-2030)
 Table 70. WuXi TIDES Company Information
 Table 71. WuXi TIDES Description and Business Overview
 Table 72. WuXi TIDES Oligonucleotide Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 73. WuXi TIDES Oligonucleotide Conjugates Product
 Table 74. WuXi TIDES Recent Developments/Updates
 Table 75. Bio-Synthesis Inc Company Information
 Table 76. Bio-Synthesis Inc Description and Business Overview
 Table 77. Bio-Synthesis Inc Oligonucleotide Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 78. Bio-Synthesis Inc Oligonucleotide Conjugates Product
 Table 79. Bio-Synthesis Inc Recent Developments/Updates
 Table 80. Creative Biolabs Company Information
 Table 81. Creative Biolabs Description and Business Overview
 Table 82. Creative Biolabs Oligonucleotide Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 83. Creative Biolabs Oligonucleotide Conjugates Product
 Table 84. Creative Biolabs Recent Developments/Updates
 Table 85. Creative Biogene (IntegrateRNA) Company Information
 Table 86. Creative Biogene (IntegrateRNA) Description and Business Overview
 Table 87. Creative Biogene (IntegrateRNA) Oligonucleotide Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 88. Creative Biogene (IntegrateRNA) Oligonucleotide Conjugates Product
 Table 89. Creative Biogene (IntegrateRNA) Recent Developments/Updates
 Table 90. CPC Scientific Inc. Company Information
 Table 91. CPC Scientific Inc. Description and Business Overview
 Table 92. CPC Scientific Inc. Oligonucleotide Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 93. CPC Scientific Inc. Oligonucleotide Conjugates Product
 Table 94. CPC Scientific Inc. Recent Developments/Updates
 Table 95. BOCSCI Inc. Company Information
 Table 96. BOCSCI Inc. Description and Business Overview
 Table 97. BOCSCI Inc. Oligonucleotide Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 98. BOCSCI Inc. Oligonucleotide Conjugates Product
 Table 99. BOCSCI Inc. Recent Developments/Updates
 Table 100. LifeTein Company Information
 Table 101. LifeTein Description and Business Overview
 Table 102. LifeTein Oligonucleotide Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 103. LifeTein Oligonucleotide Conjugates Product
 Table 104. LifeTein Recent Developments/Updates
 Table 105. Ajinomoto Company Information
 Table 106. Ajinomoto Description and Business Overview
 Table 107. Ajinomoto Oligonucleotide Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 108. Ajinomoto Oligonucleotide Conjugates Product
 Table 109. Ajinomoto Recent Developments/Updates
 Table 110. SBS Genetech Company Information
 Table 111. SBS Genetech Description and Business Overview
 Table 112. SBS Genetech Oligonucleotide Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 113. SBS Genetech Oligonucleotide Conjugates Product
 Table 114. SBS Genetech Recent Developments/Updates
 Table 115. Medtide Inc. Company Information
 Table 116. Medtide Inc. Description and Business Overview
 Table 117. Medtide Inc. Oligonucleotide Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 118. Medtide Inc. Oligonucleotide Conjugates Product
 Table 119. Medtide Inc. Recent Developments/Updates
 Table 120. Kaneka Corporation(Eurogentec) Company Information
 Table 121. Kaneka Corporation(Eurogentec) Description and Business Overview
 Table 122. Kaneka Corporation(Eurogentec) Oligonucleotide Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 123. Kaneka Corporation(Eurogentec) Oligonucleotide Conjugates Product
 Table 124. Kaneka Corporation(Eurogentec) Recent Developments/Updates
 Table 125. Rockland Company Information
 Table 126. Rockland Description and Business Overview
 Table 127. Rockland Oligonucleotide Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 128. Rockland Oligonucleotide Conjugates Product
 Table 129. Rockland Recent Developments/Updates
 Table 130. CellMosaic Company Information
 Table 131. CellMosaic Description and Business Overview
 Table 132. CellMosaic Oligonucleotide Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 133. CellMosaic Oligonucleotide Conjugates Product
 Table 134. CellMosaic Recent Developments/Updates
 Table 135. Leinco Company Information
 Table 136. Leinco Description and Business Overview
 Table 137. Leinco Oligonucleotide Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 138. Leinco Oligonucleotide Conjugates Product
 Table 139. Leinco Recent Developments/Updates
 Table 140. Lonza Company Information
 Table 141. Lonza Description and Business Overview
 Table 142. Lonza Oligonucleotide Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 143. Lonza Oligonucleotide Conjugates Product
 Table 144. Lonza Recent Developments/Updates
 Table 145. ChemExpress Company Information
 Table 146. ChemExpress Description and Business Overview
 Table 147. ChemExpress Oligonucleotide Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 148. ChemExpress Oligonucleotide Conjugates Product
 Table 149. ChemExpress Recent Developments/Updates
 Table 150. Hongene Biotech Company Information
 Table 151. Hongene Biotech Description and Business Overview
 Table 152. Hongene Biotech Oligonucleotide Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 153. Hongene Biotech Oligonucleotide Conjugates Product
 Table 154. Hongene Biotech Recent Developments/Updates
 Table 155. GTP Bioways Company Information
 Table 156. GTP Bioways Description and Business Overview
 Table 157. GTP Bioways Oligonucleotide Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 158. GTP Bioways Oligonucleotide Conjugates Product
 Table 159. GTP Bioways Recent Developments/Updates
 Table 160. Suzhou Biosyntech Company Information
 Table 161. Suzhou Biosyntech Description and Business Overview
 Table 162. Suzhou Biosyntech Oligonucleotide Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 163. Suzhou Biosyntech Oligonucleotide Conjugates Product
 Table 164. Suzhou Biosyntech Recent Developments/Updates
 Table 165. Key Raw Materials Lists
 Table 166. Raw Materials Key Suppliers Lists
 Table 167. Oligonucleotide Conjugates Distributors List
 Table 168. Oligonucleotide Conjugates Customers List
 Table 169. Oligonucleotide Conjugates Market Trends
 Table 170. Oligonucleotide Conjugates Market Drivers
 Table 171. Oligonucleotide Conjugates Market Challenges
 Table 172. Oligonucleotide Conjugates Market Restraints
 Table 173. Research Programs/Design for This Report
 Table 174. Key Data Information from Secondary Sources
 Table 175. Key Data Information from Primary Sources
 Table 176. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Oligonucleotide Conjugates
 Figure 2. Global Oligonucleotide Conjugates Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Oligonucleotide Conjugates Market Share by Type: 2023 & 2030
 Figure 4. Oligonucleotide-Peptide Product Picture
 Figure 5. Oligonucleotide-Antibody Product Picture
 Figure 6. Oligonucleotide-Lipid Product Picture
 Figure 7. Oligonucleotide-Toxin Product Picture
 Figure 8. Oligonucleotide-GalNAc Product Picture
 Figure 9. Other Product Picture
 Figure 10. Global Oligonucleotide Conjugates Market Value by Application (2024-2030) & (US$ Million)
 Figure 11. Global Oligonucleotide Conjugates Market Share by Application: 2023 & 2030
 Figure 12. Gene Therapy
 Figure 13. Drug Delivery
 Figure 14. Vaccine Development
 Figure 15. Global Oligonucleotide Conjugates Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 16. Global Oligonucleotide Conjugates Market Size (2019-2030) & (US$ Million)
 Figure 17. Global Oligonucleotide Conjugates Sales (2019-2030) & (Kg)
 Figure 18. Global Oligonucleotide Conjugates Average Price (US$/g) & (2019-2030)
 Figure 19. Oligonucleotide Conjugates Report Years Considered
 Figure 20. Oligonucleotide Conjugates Sales Share by Manufacturers in 2023
 Figure 21. Global Oligonucleotide Conjugates Revenue Share by Manufacturers in 2023
 Figure 22. Global 5 and 10 Largest Oligonucleotide Conjugates Players: Market Share by Revenue in Oligonucleotide Conjugates in 2023
 Figure 23. Oligonucleotide Conjugates Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 24. Global Oligonucleotide Conjugates Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 25. North America Oligonucleotide Conjugates Sales Market Share by Country (2019-2030)
 Figure 26. North America Oligonucleotide Conjugates Revenue Market Share by Country (2019-2030)
 Figure 27. United States Oligonucleotide Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. Canada Oligonucleotide Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. Europe Oligonucleotide Conjugates Sales Market Share by Country (2019-2030)
 Figure 30. Europe Oligonucleotide Conjugates Revenue Market Share by Country (2019-2030)
 Figure 31. Germany Oligonucleotide Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. France Oligonucleotide Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. U.K. Oligonucleotide Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Italy Oligonucleotide Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Russia Oligonucleotide Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. Asia Pacific Oligonucleotide Conjugates Sales Market Share by Region (2019-2030)
 Figure 37. Asia Pacific Oligonucleotide Conjugates Revenue Market Share by Region (2019-2030)
 Figure 38. China Oligonucleotide Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Japan Oligonucleotide Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. South Korea Oligonucleotide Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. India Oligonucleotide Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Australia Oligonucleotide Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. China Taiwan Oligonucleotide Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Southeast Asia Oligonucleotide Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Latin America Oligonucleotide Conjugates Sales Market Share by Country (2019-2030)
 Figure 46. Mexico Oligonucleotide Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Brazil Oligonucleotide Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Argentina Oligonucleotide Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Colombia Oligonucleotide Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Middle East and Africa Oligonucleotide Conjugates Sales Market Share by Country (2019-2030)
 Figure 51. Middle East and Africa Oligonucleotide Conjugates Revenue Market Share by Country (2019-2030)
 Figure 52. Turkey Oligonucleotide Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 53. Saudi Arabia Oligonucleotide Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 54. UAE Oligonucleotide Conjugates Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 55. Global Sales Market Share of Oligonucleotide Conjugates by Type (2019-2030)
 Figure 56. Global Revenue Market Share of Oligonucleotide Conjugates by Type (2019-2030)
 Figure 57. Global Oligonucleotide Conjugates Price (US$/g) by Type (2019-2030)
 Figure 58. Global Sales Market Share of Oligonucleotide Conjugates by Application (2019-2030)
 Figure 59. Global Revenue Market Share of Oligonucleotide Conjugates by Application (2019-2030)
 Figure 60. Global Oligonucleotide Conjugates Price (US$/g) by Application (2019-2030)
 Figure 61. Oligonucleotide Conjugates Value Chain
 Figure 62. Oligonucleotide Conjugates Production Process
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

RELATED REPORTS

Global Enhanced Hollow-Fiber Membrane Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19T19555
Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Disposable Wave Bioreactor Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30T17927
Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Loperamide Hydrochloride Capsules Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-18L19449
Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Add to Cart